TABLE 6.
No. (%) of Participants With Impairmenta | OR (95% CI) | P | |
---|---|---|---|
Low NEPSY-A/E | 43 (23%) | ||
PSQ | 0.81 (0.55–1.19) | .28 | |
AHI | 1.07 (0.74–1.53) | .73 | |
High BRIEF | 51 (28%) | ||
PSQ | 3.15 (2.02–4.91) | <.0001 | |
AHI | 0.68 (0.44–1.06) | .09 | |
High Connors | 47 (25%) | ||
PSQ | 4.23 (2.54–7.05) | <.0001 | |
AHI | 0.80 (0.52–1.22) | .30 | |
High CBCL | 50 (28%) | ||
PSQ | 3.13 (2.00–4.91) | <.0001 | |
AHI | 0.87 (0.58–1.29) | .48 | |
Low PedsQL (child) | 61 (33%) | ||
PSQ | 1.58 (1.13–2.22) | .008 | |
AHI | 0.89 (0.63–1.24) | .48 | |
Low PedsQL (parent) | 56 (30%) | ||
PSQ | 2.52 (1.69–3.75) | <.0001 | |
AHI | 1.10 (0.77–1.55) | .61 | |
High OSAS-18 | 49 (27%) | ||
PSQ | 5.70 (3.24–10.05) | <.0001 | |
AHI | 1.29 (0.86–1.94) | .22 | |
High ESS | 48 (26%) | ||
PSQ | 1.84 (1.26–2.68) | .002 | |
AHI | 0.96 (0.68–1.38) | .84 |
Logistic regression adjusted for age, gender, race, and BMI z score. PSQ score and AHI normalized to model the effect of a 1-SD increase (equivalent to 0.18 points on the PSQ or 5.8 points for the AHI), after adjustment for the baseline value of the other predictor and other covariates in the model.
Clinically meaningful impairment defined for this analysis as a morbidity score ≥0.5 SD worse than baseline mean.